Statin-Associated Muscle Symptoms: Contemporary Cardiology
Editat de Paul D. Thompson, Beth A. Tayloren Limba Engleză Hardback – 26 ian 2020
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS.
A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 551.64 lei 38-44 zile | |
Springer International Publishing – 26 ian 2021 | 551.64 lei 38-44 zile | |
Hardback (1) | 655.32 lei 38-44 zile | |
Springer International Publishing – 26 ian 2020 | 655.32 lei 38-44 zile |
Din seria Contemporary Cardiology
- 5% Preț: 895.26 lei
- 5% Preț: 1404.74 lei
- 5% Preț: 426.07 lei
- 5% Preț: 1167.57 lei
- 5% Preț: 480.53 lei
- 5% Preț: 1033.76 lei
- 5% Preț: 1029.26 lei
- 5% Preț: 839.02 lei
- 5% Preț: 1861.55 lei
- 5% Preț: 1396.84 lei
- 5% Preț: 1845.76 lei
- 5% Preț: 1420.35 lei
- 5% Preț: 1094.81 lei
- 5% Preț: 1897.20 lei
- 5% Preț: 702.87 lei
- 5% Preț: 1900.62 lei
- 5% Preț: 1330.76 lei
- 5% Preț: 1088.92 lei
- 5% Preț: 1411.73 lei
- 5% Preț: 1383.96 lei
- 5% Preț: 1434.48 lei
- 5% Preț: 715.23 lei
- 5% Preț: 1148.92 lei
- 5% Preț: 1315.74 lei
- 5% Preț: 1305.06 lei
- 5% Preț: 692.74 lei
- 5% Preț: 1079.98 lei
- 5% Preț: 1093.95 lei
- 5% Preț: 1085.14 lei
- 5% Preț: 1411.01 lei
- 5% Preț: 1089.09 lei
- 5% Preț: 1081.59 lei
- 5% Preț: 1416.19 lei
- 5% Preț: 721.51 lei
- 5% Preț: 1089.63 lei
- 5% Preț: 771.10 lei
- 5% Preț: 1937.43 lei
- 5% Preț: 1406.52 lei
- 5% Preț: 1087.11 lei
- 5% Preț: 1291.73 lei
- 5% Preț: 1087.81 lei
Preț: 655.32 lei
Preț vechi: 689.81 lei
-5% Nou
Puncte Express: 983
Preț estimativ în valută:
125.41€ • 130.27$ • 104.18£
125.41€ • 130.27$ • 104.18£
Carte tipărită la comandă
Livrare economică 29 ianuarie-04 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030333034
ISBN-10: 3030333035
Pagini: 188
Ilustrații: XI, 188 p. 22 illus., 16 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.5 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Seria Contemporary Cardiology
Locul publicării:Cham, Switzerland
ISBN-10: 3030333035
Pagini: 188
Ilustrații: XI, 188 p. 22 illus., 16 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.5 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Seria Contemporary Cardiology
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1. Introduction.- Chapter 2. Do Statin-Associated Muscle Symptoms (SAMS) Exist?.- Chapter 3. The Clinical Presentation of SAMS.- Chapter 4. Definitions of SAMS.- Chapter 5. The Patient’s Perspective of SAMS.- Chapter 6. Psychosocial, Emotional, and Societal Factors Influencing Perceptions and Experiences of SAMS.- Chapter 7. Prevalence of SAMS in Observational and Clinical Trials.- Chapter 8. Risk factors for SAMS.- Chapter 9. Clinical Trials of Treatments for SAMS.- Chapter 10. Clinical Management of SAMS.- Chapter 11. Effects of Statins on Exercise Performance and Exercise Training.- Chapter 12. Genetic Risk Factors for SAMS.- Chapter 13. The Role of the Mitochondria in SAMS.- Chapter 14. The Role of Energy Metabolism in SAMS.- Chapter 15. Vitamin D and SAMS.- Chapter 16. Coenzyme Q 10 and SAMS.- Chapter 17. Diagnosing SAMS.- Chapter 18. The Clinical and Financial Cost of SAMS.- Chapter19. The Interaction of Statins and Inherited Muscle Disease.- Chapter 20. The Differential Diagnosis of SAMS.- Chapter 21. Statin-Associated Inflammatory Myositis and Other Inflammatory Conditions.- Chapter 22. Managing Statin Rhabdomyolysis.- Chapter 23. Future Directions: Critical Questions and Research Approaches to Improving Understanding and Treatment of SAMS.
Notă biografică
Paul D. Thompson, MD
Chief of Cardiology Emeritus
Hartford Hospital
Hartford, CT
Professor of Medicine
University of Connecticut School of Medicine
Farmington, CT
Beth A. Taylor, PhD
Division of Cardiology
Hartford Hospital
Hartford, CT
Department of Kinesiology
University of Connecticut
Storrs, CT
Textul de pe ultima copertă
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS.
A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Caracteristici
Examines both sides of the debate on whether statin-related muscle symptoms exist Discusses risk factors, diagnosis and differential diagnosis, clinical presentations, and management Highlights the psychosocial, emotional, and societal factors influencing patients’ perceptions and experiences of SAMS Presents the results of observational and clinical trials on the prevalence and treatment of SAMS